Search results for "LOAD"

showing 10 items of 1967 documents

Outcomes of interventional sialendoscopy for obstructive salivary gland disorders: an Italian multicentre study

2016

Sebbene le tecniche scialoendoscopiche abbiano assunto un ruolo fondamentale nel trattamento delle patologie ostruttive dei dotti salivari, in letteratura sono riportati pochi studi multicentrici sull’argomento. Questo studio basato sull’esperienza di 9 centri italiani è stato con-dotto su 1152 pazienti (553 donne, età media di 50 anni) per un totale di 1342 procedure scialoendoscopiche, il 44,6% delle quali a carico della ghiandola parotide. Il 12% dei pazienti è stato sottoposto a più interventi. I calcoli salivari sono risultati essere la principale causa di ostruzione (55%), seguiti dalle stenosi e altre malformazioni duttali (16%), dai tappi mucosi (14,5%) e dalla scialodochite (4,7%).…

MaleSialodochitisSalivary ductTherapeutic Procedure0302 clinical medicineOtologySialolithiasiMedicineSialolithiasisendoscopic surgery; multicentre study; salivary ducts; salivary glands; sialendoscopy; sialoadenitis; sialolithiasis030223 otorhinolaryngologyChildSialoadenitiAged 80 and overSalivary glandSalivary ductsSialoadenitisOtorhinolaryngology2734 Pathology and Forensic MedicineMiddle AgedParotid glandGeneral Energymedicine.anatomical_structureTreatment OutcomeItaly030220 oncology & carcinogenesisChild PreschoolSalivary DuctsFemaleAdultmedicine.medical_specialtyAdolescentSalivary glandsMulticentre studySialadenitis03 medical and health sciencesYoung AdultHumansSialendoscopyAgedRetrospective Studiesbusiness.industryEndoscopic surgery; Multicentre study; Salivary ducts; Salivary glands; Sialendoscopy; Sialoadenitis; Sialolithiasis;Salivary Gland DisorderEndoscopymedicine.diseaseEndoscopic surgerySurgeryStenosisOtorhinolaryngologySalivary Gland DiseasesSalivary Duct Calculibusiness
researchProduct

Sialodochoplasty in the treatment of salivary-duct stricture in chronic sialoadenitis: technique and results

2007

PURPOSE: This study was undertaken to investigate peroral balloon angioplasty of salivary-duct strictures (sialodochoplasty) in chronic sialadenitis, analysing the technique, results and limitations. MATERIALS AND METHODS: Nine patients underwent sialodochoplasty: seven for Stensen''s-duct strictures and two for Wharton''s-duct strictures. One patient had a double stricture of Stensen''s duct and another a salivary stone associated with a Wharton''s-duct stricture. All patients were subjected to preliminary sialography to evaluate stricture site, length and grade. Sialodochoplasty was performed after local anaesthesia and progressive dilation of the salivary-duct orifice. RESULTS: The stric…

MaleSialodochoplastymedicine.medical_specialtySialographymedicine.medical_treatmentSettore MED/50 - Scienze Tecniche Mediche ApplicateSalivary duct strictureSalivary Gland DiseasesSIALODOCOPLASTY SIALOADENITISConstriction PathologicBalloonSialadenitisCatheterizationRecurrenceAngioplastyChronic sialoadenitisHumansSalivary DuctsMedicineRadiology Nuclear Medicine and imagingmedicine.diagnostic_testbusiness.industryInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseFibrosisSialadenitisSurgeryTreatment OutcomeSettore MED/31 - OtorinolaringoiatriaFluoroscopyChronic DiseaseSalivary Duct CalculiFemaleSialographyRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessFollow-Up StudiesLa radiologia medica
researchProduct

Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C

2007

OBJECTIVES: The aims of this study were to investigate the expression of cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) in chronic hepatitis C (CHC) by immunohistochemistry, based on the hypothesis that COXs expression could vary according to genotype, viral load, liver steatosis, BMI and response to therapy and to determine whether the addition of selective COX inhibitors could have a rationale in increasing the efficacy of antiviral therapy. METHODS: We used 35 formalin-fixed, paraffin-embedded liver tissue samples obtained by needle biopsy from patients with CHC (17F/18M) with one of two types of genotype (1b and 3a). The presence of COX-1 and COX-2 in the cytoplasm of hepatocyt…

MaleSteatosisGene ExpressionHepacivirusChronic hepatitis CGastroenterologychemistry.chemical_compoundmedicine.diagnostic_testFatty liverGastroenterologyMiddle AgedImmunohistochemistryRecombinant ProteinsCyclooxygenaseTreatment OutcomeLiverRNA ViralFemaleViral loadmedicine.drugAdultmedicine.medical_specialtyAdolescentGenotypeCombination therapyAlpha interferonInterferon alpha-2Antiviral AgentsInternal medicineRibavirinBiopsymedicineHumansInterferon alfaAgedStaining and LabelingHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C AntibodiesHepatitis C Chronicmedicine.diseasechemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesImmunologyCyclooxygenase 1SteatosisbusinessInterferon-αEuropean Journal of Gastroenterology & Hepatology
researchProduct

Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with H…

2016


 
 
 
 
 
 Background & Aims: Smoking has multiple effects on factors influencing hepatitis C and antiviral therapy, including lipid metabolism, fibrosis, platelet count and adherence aspects. The aim of this analysis was to determine the impact of smoking on hepatitis C virus antiviral therapy.
 Methods: Data of two cohorts of an observational multicenter study including therapy-naïve patients infected with genotype 1 hepatitis C virus (HCV) treated with dual antiviral therapy (n=7,796) with pegylated interferon alpha 2a in combination with ribavirin, or triple antiviral therapy (n=1,122) containing telaprevir or boceprevir, were analysed.
 Resu…

MaleTime Factors030508 substance abuseHepacivirusmedicine.disease_causeGastroenterologyTelaprevirPolyethylene Glycolschemistry.chemical_compound0302 clinical medicineRisk FactorsGermanyOdds RatioAged 80 and overSmokingGastroenterologyHepatitis CMiddle AgedViral LoadHepatitis CRecombinant ProteinsTreatment OutcomeDrug Therapy CombinationFemale0305 other medical scienceViral loadOligopeptidesmedicine.drugAdultmedicine.medical_specialtyAdolescentGenotypeProlineHepatitis C virusAlpha interferonAntiviral Agents03 medical and health sciencesYoung AdultBoceprevirInternal medicineRibavirinmedicineHumansProtease inhibitor (pharmacology)Protease InhibitorsAgedbusiness.industryRibavirinInterferon-alphamedicine.diseaseVirology030227 psychiatryLogistic ModelschemistryMultivariate AnalysisbusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

2021

Background and aims: Beyond type 2 diabetes, even a condition of prediabetes is associated with an increased cardiovascular (CV) risk, and HCV infection coexistence represents an exacerbating factor. CV prognosis improvement in prediabetes represents a challenge, due to the increasing prevalence of this metabolic condition worldwide. Hence, we aimed to prospectively assess how direct acting antivirals (DAAs) could affect major cardiovascular events (MACE) in a prediabetic HCV positive cohort. Methods and results: In this prospective multicenter study, we enrolled HCV patients with overt prediabetes. We compared a subgroup of patients treated with DAAs with untreated prediabetic controls. We…

MaleTime FactorsEndocrinology Diabetes and MetabolismCardiovascular risk Direct acting antiviralsHepatitis C virusPrediabetes Aged Antiviral Agents Cardiovascular Diseases FemaleHeart Disease Risk Factors Hepatitis C Humans Incidence Italy Longitudinal Studies Male Middle Aged Prediabetic State Prospective Studies Protective Factors Retrospective Studies Risk AssessmentTime Factors Treatment Outcome Viral LoadMedicine (miscellaneous)Type 2 diabetes030204 cardiovascular system & hematologymedicine.disease_causeDIRECT ACTING ANTIVIRALSLiver disease0302 clinical medicineLongitudinal StudiesProspective StudiesPrediabeteseducation.field_of_studyNutrition and DieteticsIncidenceMiddle AgedViral LoadHepatitis CTreatment OutcomeItalyCardiovascular DiseasesCohortFemaleCardiology and Cardiovascular Medicinemedicine.medical_specialtyHepatitis C virusPopulation030209 endocrinology & metabolismAntiviral AgentsRisk AssessmentPrediabetic State03 medical and health sciencesInternal medicinemedicineHumanseducationAgedRetrospective Studiesbusiness.industryProtective FactorsCardiovascular riskmedicine.diseaseHeart Disease Risk FactorsDirect acting antiviralHepatitis C virubusinessPrediabetesMace
researchProduct

Straight and tilted implants for supporting screw-retained full-arch dental prostheses in atrophic maxillae : a 2-year prospective study

2018

Background To evaluate, over a 2-year period, the treatment outcomes for maxillary full-arch fixed dental prostheses (FDPs) supported by a combination of both tilted and axially-placed implants and to compare the marginal bone loss (MBL) and implant survival rates (SR) between tilted and axial implants. Material and Methods A retrospective study has been carried out. Thirty-two patients (16 males and 16 females) treated with maxillary full-arch FDPs were included in this retrospective study. A total of 187 implants were inserted to rehabilitate the fully edentulous maxillary arches: 36% of them were tilted (T group, n = 68) and the remaining 64% were axially placed (A group, n = 119). From …

MaleTime FactorsRadiographyBone ScrewsDentistry03 medical and health sciences0302 clinical medicineDental Prosthesis DesignMaxillaMedicineHumans030212 general & internal medicineImplant loadingProspective StudiesProspective cohort studyGeneral DentistryRetrospective Studiesbusiness.industryResearchDental prosthesis030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Screw retainedOtorhinolaryngologyDental Prosthesis DesignMaxillaUNESCO::CIENCIAS MÉDICASSurgeryFemaleImplantDental Prosthesis Implant-SupportedAtrophyOral Surgerybusiness
researchProduct

''Active Collisions in Altered Gravity Reveal Eye-Hand Coordination Strategies''

2012

White, Olivier | Lefevre, Philippe | Wing, Alan M. | Bracewell, R. Martyn | Thonnard, Jean-Louis; International audience; ''Most object manipulation tasks involve a series of actions demarcated by mechanical contact events, and gaze is usually directed to the locations of these events as the task unfolds. Typically, gaze foveates the target 200 ms in advance of the contact. This strategy improves manual accuracy through visual feedback and the use of gaze-related signals to guide the hand/ object. Many studies have investigated eye-hand coordination in experimental and natural tasks; most of them highlighted a strong link between eye movements and hand or object kinematics. In this experime…

MaleTime Factorsgenetic structuresComputer sciencelcsh:MedicineAstronomical SciencesKinematicsSocial and Behavioral SciencesInertiaDIRECTION''Behavioral NeuroscienceLearning and MemoryHuman PerformancePsychologyComputer visionOBJECT MANIPULATIONlcsh:ScienceDIRECTIONmedia_commonGravity AlteredMultidisciplinaryEye–hand coordinationHand StrengthWeightlessnessMiddle AgedSpace ExplorationSensory SystemsBiomechanical PhenomenaTARGET[ SCCO.NEUR ] Cognitive science/NeuroscienceGRIP FORCE ADJUSTMENTSFemaleResearch ArticleAdult''GRIP FORCE ADJUSTMENTSMovementCognitive Neurosciencemedia_common.quotation_subjectAccelerationFixation OcularYoung AdultVISUAL INFORMATIONLOAD PERTURBATIONSHand strengthSaccadesHumansWorking MemoryBiologyHEAD MOVEMENTSARM MOVEMENTSMotor SystemsBehaviorHypergravityWeightlessnessbusiness.industryLatency Period Psychologicallcsh:REye movementSpaceflightHandCollisionGazePOINTING MOVEMENTFixation (visual)TASKlcsh:QArtificial intelligencebusinessNeuroscience
researchProduct

Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab.

2010

PURPOSE The purpose of this study was to report the visual outcome of intravitreal therapy with ranibizumab of choroidal neovascularization secondary to angioid streaks after 1-year follow-up. METHODS Nine patients (age, 58 +/- 4 years; range, 53-65 years) were treated with off-label intravitreal injections of 0.3 mg ranibizumab. Primary outcomes were best-corrected visual acuity changes (Early Treatment Diabetic Retinopathy Study logarithm of the minimum angle of resolution and letters) and optical coherence tomography macular thickness changes. RESULTS Mean follow-up was 14 months (+/-2; range, 12-18 months). Mean visual acuity was 0.52 logarithm of the minimum angle of resolution and 30 …

MaleVascular Endothelial Growth Factor Amedicine.medical_specialtyVisual acuitygenetic structuresVisual AcuitymonoclonalAngiogenesis InhibitorsAntibodies Monoclonal HumanizedLoading doseChoroidal neovascularization; male; treatment outcome; injections; middle aged; vascular endothelial growth factor a; female; vitreous body; humans; retreatment; visual acuity; angiogenesis inhibitors; aged; angioid streaks; antibodies monoclonalInjectionsNeovascularizationOptical coherence tomographyOphthalmologyRanibizumabMedicineantibodiesHumansANTI-VEGFAgedintravitreal ranibizumabmedicine.diagnostic_testbusiness.industrySettore MED/30 - Malattie Apparato VisivoAntibodies MonoclonalGeneral MedicineDiabetic retinopathyMiddle Agedmedicine.diseaseeye diseasesChoroidal NeovascularizationVitreous BodyOphthalmologyAngioid streaksChoroidal neovascularizationTreatment OutcomeRetreatmentAngioid StreaksFemalemedicine.symptomRanibizumabbusinessAngioid streak-related choroidal neovascularizationmedicine.drugRetina (Philadelphia, Pa.)
researchProduct

Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection.

2013

Background Visceral leishmaniasis is a parasitic disease associated with high mortality. The most important foci of visceral leishmaniasis in Ethiopia are in the Northwest and are predominantly associated with high rates of HIV co-infection. Co-infection of visceral leishmaniasis patients with HIV results in higher mortality, treatment failure and relapse. We have previously shown that arginase, an enzyme associated with immunosuppression, was increased in patients with visceral leishmaniasis and in HIV seropositive patients; further our results showed that high arginase activity is a marker of disease severity. Here, we tested the hypothesis that increased arginase activities associated wi…

MaleViral Diseasesmedicine.medical_treatmentEnzyme MetabolismHIV InfectionsParasite loadBiochemistrySeverity of Illness Index0302 clinical medicineBlood plasmaSUPPRESSOR-CELLSMACROPHAGESPLASMA AMINO-ACIDS0303 health sciencesCoinfectionPARASITOLOGYlcsh:Public aspects of medicineImmunosuppression11 Medical And Health SciencesIMMUNODEFICIENCY-VIRUS TYPE-13. Good healthEnzymesSEROPOSITIVE PATIENTSArginaseInfectious DiseasesCoinfectionMedicineLeishmaniasis VisceralBiological MarkersLife Sciences & BiomedicineResearch ArticleNeglected Tropical DiseasesAdultlcsh:Arctic medicine. Tropical medicineAdolescentlcsh:RC955-962030231 tropical medicineINHIBITIONPeripheral blood mononuclear cellMECHANISMS03 medical and health sciencesYoung AdultDONOVANITropical MedicinemedicineParasitic DiseasesACTIVATED GRANULOCYTESHumansAdolescent; Adult; Arginase/blood; Biological Markers/blood; Coinfection/diagnosis; Coinfection/pathology; Cross-Sectional Studies; Ethiopia; HIV Infections/complications; HIV Infections/diagnosis; Humans; Leishmaniasis Visceral/complications; Leishmaniasis Visceral/diagnosis; Male; Severity of Illness Index; Young AdultBiology030304 developmental biologyScience & TechnologyArginasebusiness.industryPublic Health Environmental and Occupational HealthLeishmaniasislcsh:RA1-127006 Biological Sciencesmedicine.diseaseVisceral leishmaniasisCross-Sectional StudiesImmunologyEthiopiabusinessBiomarkersRESPONSES
researchProduct

Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD

2019

Bruno Balbi,1 Claudia Sangiorgi,1 Isabella Gnemmi,1 Ilaria Ferrarotti,2 Davide Vallese,1 Elena Paracchini,1 Lorena Delle Donne,1 Luciano Corda,3 Paolo Baderna,4 Angelo Corsico,2 Mauro Carone,1 Paola Brun,5 Francesco Cappello,6,7 Fabio LM Ricciardolo,8 Paolo Ruggeri,9 Sharon Mumby,10 Ian M Adcock,10 Gaetano Caramori,9 Antonino Di Stefano11Istituti Clinici Scientifici Maugeri, IRCCS, Division of Pneumology and Laboratory of Cytoimmunopathology of the Heart and Lung, Veruno, Italy; 2Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy; 3Medicina Respiratoria, Seconda Medicina Interna, Spedali Civili, Brescia, Italy; 4Division of Pneumology, Aosta Hospital, Aos…

Malealpha-1 antitrypsin deficiency COPD chronic inflammationchronic inflammationINTERLEUKIN-27AIRWAY INFLAMMATIONRespiratory SystemInternational Journal of Chronic Obstructive Pulmonary DiseaseFREQUENCYACTIVATIONPulmonary Disease Chronic ObstructiveRisk Factorsalpha 1-Antitrypsin DeficiencyHumansCOPD1102 Cardiorespiratory Medicine and HaematologyLungNEUTROPHILSAgedOriginal Researchlcsh:RC705-779Science & TechnologyBacteriaSmokingsputumrespiratory disabilitylcsh:Diseases of the respiratory systemMiddle AgedMICROBIOTABacterial Loadrespiratory tract diseaseschronic airway inflammationCHRONIC-BRONCHITISalpha-1 antitrypsin deficiencyCase-Control StudiesAlpha-1 antitrypsin deficiencyHost-Pathogen InteractionsAUGMENTATION THERAPYFemaleInflammation MediatorsLife Sciences & BiomedicineAlpha-1 antitrypsin deficiency; Chronic airway inflammation; COPD; Respiratory disability; SputumInternational Journal of COPD
researchProduct